Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Apply
TEV-56278 & Pembrolizumab
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step